Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ADC-THERAPEUTICS-SA-66481721/news/ADC-Therapeutics-and-Sobi-Announce-European-Commission-Approval-of-ZYNLONTA-for-the-Treatment-of-Rel-42597659/?utm_source=whatsapp&utm_medium=social&utm_campaign=share